Skip to content
★ Sign in to follow
ST

Stayble Therapeutics AB Stock: price and insider trades · Sweden

ISIN SE0015504121SE·Mcap SEK 13.2M

No insider purchase over the last 90 days. The latest, by Andreas Gerward, was filed 06 Dec 2024.

Stayble Therapeutics AB: what insiders have been doing

Stayble Therapeutics AB is a listed company. Its insiders report their share dealings to Finansinspektionen. Stayble Therapeutics AB has had no insider filing for more than a year; the last one goes back to 6 December 2024.

The full history, which starts in 2020, counts 19 purchases against 2 sales.

Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Insider Decl.
40
Thresholds
n/a
Buy Volume
€62,800
19 ops. · all time
Sell Volume
€140,091
2 ops. · all time

Who traded when

BuySale
Andreas Gerward1 buy

Financial data

as of FY 2025

FY ended December 2025 · cache

SEK 0.21
Analyst consensus
·
Income statement
EBITDA-SEK 6.9M
Net income-SEK 6.9M0.0% margin
Valuation
P/Book1.9x
Beta-0.88
Balance sheet & cash
Market capSEK 13.2M
Total debtSEK 850k
Free Cash Flow-SEK 6.7M
Debt / Equity12%
Profitability & ownership
ROE-100.4%
ROA-48.8%
% insiders21.5%
% institutions21.4%
Last declaration on 6 December 2024
Declarations40 total
  • ▲
    Verkställande direktör (VD)Executives
    18,800 SEK23FI-SE
    40,000 shares@ SEK 0.4713.4% of flowAktieISIN SE0013513652FI:csv-ee078ff813c5631a5441
    Canonical exit: 6 Mar 2025 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutives
    10,240 SEK32FI-SE
    32,000 shares@ SEK 0.3210.4% of flowAktieISIN SE0013513652FI:csv-bec7d04ba1f19f06af92
    Canonical exit: 10 Sept 2024 (T+90)
  • ▲
    Verkställande direktör (VD)Executives
    48,000 SEK26FI-SE
    160,000 shares@ SEK 0.3035.1% of flowAktieISIN SE0013513652FI:csv-02ade8dda4e159d2f0b5
    Canonical exit: 10 Sept 2024 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutives
    13,900 SEK20FI-SE
    50,000 shares@ SEK 0.27814.1% of flowAktieISIN SE0013513652FI:csv-0ee06b8ea4407fa9a9e8
    Canonical exit: 7 Mar 2024 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutives
    9,600 SEK20FI-SE
    5,000 shares@ SEK 1.929.5% of flowAktieISIN SE0013513652FI:csv-08ed8dc4d5245cfdbae6
    Canonical exit: 12 Oct 2023 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutives
    109,973 SEK0FI-SE
    5,000 shares@ SEK 21.9946AktieISIN SE0013513652FI:csv-3e40ab153d8f6d316d35
    Canonical exit: 12 Oct 2023 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutives
    38,400 SEK23FI-SE
    30,000 shares@ SEK 1.2838.0% of flowAktieISIN SE0013513652FI:csv-fa02a9d396ebf70c3e30
    Canonical exit: 22 Aug 2023 (T+90)
  • ●
    Annan ledande befattningshavareExecutives
    11,855 SEK0FI-SE
    6,660 shares@ SEK 1.7819.3% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-6af7ee43d2e70e5c42df
  • ●
    Annan ledande befattningshavareExecutives
    11,855 SEK0FI-SE
    6,660 shares@ SEK 1.7819.1% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-ffccd2a58b17a4815b0b
  • ▲
    StyrelseledamotExecutives
    40,940 SEK0FI-SE
    23,000 shares@ SEK 1.78100.0% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-6d35facc8695abc558dc
    Canonical exit: 16 Jul 2023 (T+90)
  • ▲
    StyrelseledamotExecutives
    79,993 SEK0FI-SE
    44,940 shares@ SEK 1.78100.0% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-3d3c65b39ee879d8df71
    Canonical exit: 13 Jul 2023 (T+90)
  • ●
    Annan ledande befattningshavareExecutives
    38,128 SEK0FI-SE
    21,420 shares@ SEK 1.7861.6% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-21be503e54248e640839
  • ●
    Annan ledande befattningshavareExecutives
    0FI-SE
    15,000 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-89fbe70443145e06a654
  • ●
    Verkställande direktör (VD)Executives
    71,200 SEK0FI-SE
    40,000 shares@ SEK 1.7851.4% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-b014ac7f2290b20f22a9
  • ●
    Verkställande direktör (VD)Executives
    0FI-SE
    28,000 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-fecd16564f29b9e882b8
  • ●
    Verkställande direktör (VD)Executives
    0FI-SE
    250,599 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-bf8dd7d3ab3a59aad247
  • ●
    Ekonomichef/finanschef/finansdirektörExecutives
    0FI-SE
    8,000 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-6b35c146bf06c19ac8c2
  • ●
    Ekonomichef/finanschef/finansdirektörExecutives
    0FI-SE
    3,000 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-a3a5252eb93aa7cdbdb2
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutives
    20,328 SEK0FI-SE
    11,420 shares@ SEK 1.7820.4% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-d40602e3759420b06e67
    Canonical exit: 11 Jul 2023 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutives
    7,618 SEK0FI-SE
    4,280 shares@ SEK 1.787.6% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-8eabebea7d339f938d53
    Canonical exit: 11 Jul 2023 (T+90)
  • ▼
    Annan ledande befattningshavareExecutives
    0FI-SE
    90,000 sharesTeckningsrätt/UniträttISIN SE0019912866FI:csv-34c5ea5b35ccb0203365
  • ●
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
    0FI-SE
    190,000 shares0Teckningsrätt/UniträttFI:csv-99f7d9681563d9a28410
  • ●
    Verkställande direktör (VD)Executives
    0FI-SE
    81,401 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-6288494d2dbbdc02f691
  • ●
    Verkställande direktör (VD)Executives
    0FI-SE
    30,000 shares0AktieISIN SE0013513652FI:csv-4a9cedb78c3fbc59ae14
  • ▲
    Verkställande direktör (VD)Executives
    73,350 SEK0FI-SE
    15,000 shares@ SEK 4.89AktieISIN SE0013513652FI:csv-d3654bc9db0e699c91d6
    Canonical exit: 29 Nov 2022 (T+90)

25 of 40 declarations

About Stayble Therapeutics AB

Stayble Therapeutics AB is a biopharmaceutical company focused on developing treatments for chronic pain. It is listed on the XSTO exchange.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations